Table 1.
Assay | Primer/probe | Sequence (5′-3′) | Genomic location* | Amplicon | |
---|---|---|---|---|---|
N gene assay | IPBCAMS assays | Forward | AACACAAGCTTTCGGCAGAC | 29083−29102 | 195 bp |
Reverse | ACCTGTGTAGGTCAACCACG | 29278−29259 | |||
Probe | CAGCGCTTCAGCGTTCTTCGGAATGTCGC | 29200−29228 | |||
WHO assays | Forward | CACATTGGCACCCGCAATC | 28706−28724 | 127 bp | |
Reverse | GAGGAACGAGAAGAGGCTTG | 28833−28814 | |||
Probe | ACTTCCTCAAGGAACAACATTGCCA | 28753−28777 | |||
CCDC assays | Forward | GGGGAACTTCTCCTGCTAGAAT | 28881−28902 | 98 bp | |
Reverse | CAGACATTTTGCTCTCAAGCTG | 28979−28958 | |||
Probe | TTGCTGCTGCTTGACAGATT | 28934−28953 | |||
ORF 1b gene assay | IPBCAMS assays | Forward | ACGGTGACATGGTACCACAT | 13760−13779 | 215 bp |
Reverse | CTAAGTTGGCGTATACGCGT | 13975−13956 | |||
Probe | TACACAATGGCAGACCTCGTCTATGC | 13804−13829 | |||
WHO assays | Forward | GTGARATGGTCATGTGTGGCGG | 15431−15452 | 99 bp | |
Reverse | CARATGTTAAASACACTATTAGCATA | 15530−15505 | |||
Probe | CAGGTGGAACCTCATCAGGAGATGC | 15470−15494 | |||
CCDC assays | Forward | CCCTGTGGGTTTTACACTTAA | 13342−13362 | 118 bp | |
Reverse | ACGATTGTGCATCAGCTGA | 13460−13442 | |||
Probe | CCGTCTGCGGTATGTGGAAAGGTTATGG | 13377−13404 |
Numbering according to a reference genome of SARS-CoV-2 (MN908947.3).